A major limitation of recently developed methods for the generation of endometrial gland organoids is their reliance on decidua isolated from endometrial biopsies or elective termination of pregnancies. Here we report the successful establishment of endometrial gland organoids from decidua isolated from term placental membranes, as well as the identification of potential survival factors for the co-culture of gland organoids and endometrial stromal fibroblasts. These modifications facilitate the generation of patient-specific endometrial gland organoids with known pregnancy outcomes, such as term vs. preterm birth.
outcomes (e.g. term vs. preterm), thus cannot be used to generate patient-specific organoids with known pregnancy histories. To determine if endometrial gland organoids can be derived from post-partum tissue, we isolated decidua from term placental membranes and followed the protocol described in Burton et al. (2017) to derive gland organoids. Briefly, after digesting the decidua and releasing the gland elements from the surrounding stromal cells, glands were resuspended in Matrigel, plated in 48-well plates and overlaid with the Expansion Medium (ExM; Supplementary Data). Spheroids resembling previously described gland organoids (Turco et al., 2017) began to appear 10-14 days after plating and could be passaged and recovered after freezing (Figure 1) .
We found that these organoids expressed classical markers of endometrial epithelial cells, including E-cadherin (E-CAD), Laminin (LAMA4), and Cytokeratin 7 (KRT7), consistent with an epithelial origin (Czernobilsky et al., 1984; Aplin, Charlton and Ayad, 1988; Inoue et al., 1992) , as well as the progesterone receptor (PR), which is expressed by luminal and gland epithelia in the endometrium and decidua (Wang et al., 1998) (Figure 2, Supplementary  Figure 1 ). These organoids also express Vimentin (VIM; Figure 2) , which is generally considered a marker of endometrial stromal fibroblasts (ESFs) (Can, Tekeliioǧlu and Baltaci, 1995) , but is also present in endometrial glands in vivo (Dabbs, Geisinger and Norris, 1986; Matthews et al., 1992) . RNA-Seq of unprocessed glands, stromal cells, and organoids confirmed the expression of Vimentin in all three samples. Surprisingly, organoids clustered with endometrial stromal fibroblasts, rather than with isolated gland elements ( Figure 3A) . However, isolated glands likely contain multiple cell types giving them a unique gene expression profile. Indeed, numerous genes with expression enriched in the placenta are expressed in the gland samples, suggesting they contain placenta-derived cells ( Table 1) .
We next sought to determine if these gland organoids were hormone responsive by treating them with β-estradiol (E2), progesterone (P4) and adenosine 3',5'-cyclic monophosphate (cAMP), and assaying gene expression by qRT-PCR. We verified that PAEP, SPP1 and HSD17B2, previously characterized markers of hormone responsiveness in glands and gland organoids (Borthwick et al., 2003; Kamarainen et al., 1993; Briese et al., 2006; Satyaswaroop, Wartell and Mortel, 1982; Turco et al., 2017) , were differentially expressed after hormone treatment ( Figure 3B) . These data indicate that gland organoids derived from term placentas maintain appropriate hormone responsiveness after isolation and culture. Collectively, our results demonstrate that endometrial gland organoids can be established from decidua isolated from term placentas, allowing for the generation of patient-specific organoids with known pregnancy outcomes.
To establish an organoid model that better recapitulates the cellular composition of the endometrium, we also isolated endometrial stromal fibroblasts (ESFs) from placentas for coculture with organoids. We found that ESFs cultured in ESF media grew well, whereas they died within a few days when cultured in ExM. Surprisingly, however, ESFs survived in ExM initially conditioned by organoids for three days, suggesting that organoids express an ESF survival factor(s). This prompted us to analyze organoid-conditioned ExM by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) to identify secreted proteins that may function in promoting ESF survival in ExM. We found 11 proteins that were significantly enriched in organoid-conditioned ExM compared to control ExM, including 5 that are not expressed by ESFs ( Supplementary Table 1 ). While further investigation of these findings is needed, our results suggest these secreted proteins act as possible survival factors.
Here we demonstrate that endometrial gland organoids can be derived from decidua isolated from post-partum placentas, facilitating the establishment of patient-derived organoids, while providing greater simplicity and minimizing ethical objections associated with tissues collected from biopsies or elective pregnancy terminations. Our observation that ESFs can survive in ExM also opens the possibility of building a more realistic 3-dimensional representation of maternal-fetal interface in vitro, incorporating multiple biologically relevant cell types.
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Passaging and Freezing
Passaging and freezing were done as described in Burton et al. (2017) . Passaging was performed as needed, when organoids were abundant and still spherical. They can grow large, but then they start collapsing onto themselves.
Pelleting was performed by centrifugation at 600g for 6 minutes and, unless otherwise noted, in 1ml of Advanced DMEM/F12.
Passaging
Matrigel droplets containing organoids were scraped off the plate using low binding pipette tips, transferred together with ExM to the low binding tubes (3-4 wells per tube) and pelleted. After removing the supernatant and adding 250μl of Advanced DMEM/F12, organoids were broken by pipetting up-and-down for 300 times. Broken organoids were pelleted again and pipetted up-and-down for additional 80 times. After final centrifugation and removing the supernatant, pellets were cooled on ice for 1-2 minutes, resuspended in Matrigel and 20-25μl droplets were plated as described above. For breaking the Matrigel droplets, we used Picus electronic pipette 50-1000ul [Sartorius, 735081] . First 300x pipetting step was performed at setting 9 (highest), second 80x pipetting step at setting 7.
Freezing
Before freezing, ExM was exchanged for 250μl Cell Recovery Solution [Corning, 354253] and the organoids were incubated for 1 hour on ice. Well content was collected in low binding tubes and pelleted. After removing the supernatant, organoids were washed with 1ml of Advanced DMEM/F12 and pelleted again. Finally, the pellet was resuspended in 500μl Recovery Cell Culture Freezing Medium [Thermo Fisher Scientific, 12648010], transferred to cryovials in a freezing container and left at -80°C overnight. Long-term storage should be in the vaporous phase of liquid N2.
Establishment of Primary Endometrial Stromal Fibroblasts Culture
After stopping the decidua digest and filtering through 100μm sieve, 6ml aliquot from the flow-through was directly pipetted into T25 cell culture flask and placed in the humidified cell culture incubator at 37°C and 5% CO2. The next day, the remaining floating blood cells were washed away with DPBS [Thermo Fisher Scientific, 14190250] and the ESF medium was added (see below). Medium was exchanged every 3 days and the expansion of few initially attached endometrial stromal fibroblasts (ESFs) was observed. It takes about 2 weeks for the cells to become confluent. From then on, ESFs can be expanded by passaging every 2-3 days.
To passage ESFs, cells are rinsed with DPBS and de-attached from the dish by incubation in 0.05% Trypsin-EDTA, no phenol red [Thermo Fisher Scientific, 15400-054] for 3-5 minutes in the humidified incubator at 37°C and 5% CO2. Trypsinisation is stopped with the ESF medium and cells are pelleted by centrifugation at 200g for 5 minutes. Pellet is resuspended in the appropriate volume of medium and cells were plated to new cell culture flasks. For the longterm storage, cells can be frozen and kept in the vaporous phase of liquid N2. The freezing medium is ESF medium supplemented with 5% dimethyl sulfoxide [DMSO; Thermo Fisher Scientific, BP231]. 
Immunofluorescence and Confocal Microscopy
When organoids were abundant, they were fixed directly in 48-well plate as follows: ExM was removed and exchanged with 250μl cold 4% paraformaldehyde (PFA) in DPBS. Organoids were incubated for 20 minutes at room temperature and washed 3x10 minutes in 500μl DPBS prior to staining.
Staining steps:
If not otherwise noted, all the steps were performed at room temperature and all the washes were done 3x10 minutes in 500μl DPBS. For detecting intra-cellular progesterone receptor (PR), fixed organoids were permeabilized for 10 minutes in 250μl 0.25% Triton X-100 in DPBS and washed. 
RNA Isolation and cDNA Synthesis
Organoids were incubated in 250μl Cell Recovery Solution for 1 hour on ice. Well content was collected in low binding tubes and pelleted by centrifugation at 600g for 6 minutes. After removing the supernatant, organoids were washed with 1ml of Advanced DMEM/F12 and pelleted again. RNA was isolated from the pellet using RNeasy Plus Mini kit [QIAGEN, 74134] following manufacturer's protocol.
cDNA was synthesized from 200ng input RNA, using the Maxima H Minus First Strand cDNA Synthesis Kit [Thermo Fisher Scientific, K1652] with oligo(dT)18 primers and incubating samples as follows: 10 minutes at 23°C, 15 minutes at 55°C, 5 minutes at 80°C.
Hormonal Treatment and qRT-PCR
Organoids from 2 different donors were passaged and grown for 2-4 days, treated with 10nM β-estradiol [E2, Sigma E4389] in ExM for 48 hours and then treated with 10nM βestradiol, 1μM progesterone [P4, Sigma P7556] and 1μM 8-bromoadenosine 3′,5′-cyclic monophosphate [cAMP; Sigma B5386]. After an additional 48 hours, RNA was isolated as described above and relative expression levels of PAEP (Hs01046125_m1), SPP1 (Hs00959010_m1) and HSD17B2 (Hs00157993_m1) were measured in triplicates by qRT-PCR. Control housekeeping genes were TBP (Hs00427620_m1) and TOP1 (Hs00243257_m1). We used TaqMan Fast Universal PCR Master Mix 2x [Thermo Fisher Scientific, 4352042] and followed manufacturer's protocol. DeltaCt values were calculated using Microsoft Excel and fold differences were plotted as a scatter plot in RStudio version 1.2.1335 [RStudio, Inc.] .
qRT-PCR program:
1. 95°C, 30s 2. 95°C, 5s 3. 60°C, 30s + plate read 4. GO TO 2 x 50 5. END
RNA-Seq and Data Analysis
RNA was isolated from: unprocessed gland elements (small aliquot collected from the sieve after filtering the initial digest of decidua), growing organoids and endometrial stromal fibroblasts isolated from the same samples and established as primary cell cultures. After DNase treatment with TURBO DNA-free Kit [Thermo Fisher Scientific, AM1907], RNA quality and quantity were assessed on 2100 Bioanalyzer [Agilent Technologies, Inc.]. RNA-Seq libraries were prepared using TruSeq Stranded Total RNA Library Prep Kit with Ribo-Zero Human [RS-122-2201, Illumina Inc.] and following manufacturer's protocol. Library quality and quantity were checked on 2100 Bioanalyzer and the pool of libraries was sequenced on Illumina HiSEQ4000 (single-end 50bp) using manufacturer's reagents and protocols. DNase treatment, quality control, Ribo-Zero library preparation and Illumina sequencing were performed at the Genomics Facility at The University of Chicago.
All sequencing data were uploaded and analyzed on the Galaxy platform (public server https://usegalaxy.org, Version 19.05), converted using FASTQ Groomer and aligned using HISAT2. We assembled transcripts using StringTie, with reference GTF file and "Reference Transcripts Only" option, followed by DESeq2 to calculate differential gene expression. The reference GTF file for guided assembly was done by StringTie merge of separately generated String Tie files (this time without "Reference Transcripts Only" option) and ensGene table from "Ensembl Genes" track from UCSC Genome Browser (GRC37/hg19 assembly).
Mass Spectrometry Analysis of Conditioned ExM
Fresh ExM was added to the growing organoids and also to the empty Matrigel droplets. After 3 days in the culture, organoid-conditioned and Matrigel-conditioned media were collected, as well as the aliquot from unconditioned ExM. 1x of Halt TM Protease Inhibitor Single-Use Cocktail 100x [Thermo Fisher Scientific, 78430] was added to all 3 samples and the samples were snap-frozen in liquid N2.
Sample preparation, LC-MS/MS and data analysis were performed at the Mass Spectrometry Core of The University of Illinois at Chicago as described below.
Sample preparation: 100μl of each sample was taken and processed following standard S-Trap protocol [Protifi, S-Trap™ micro kit, K02-micro-10]. Samples underwent tryptic digestion and desalting, the residue was reconstituted into 50μl of 5% ACN in water with 0.1% FA, then further diluted 10-fold for LC-MS/MS analysis.
LC-MS/MS method:
Samples were analyzed by nanoLC-HRMS system [Thermo Orbitrap Velos Pro]. For each sample 1μl was injected, peptides were eluted on a reverse phase C18 column via 1 hr gradient LC program. Mobile phase A: water with 0.1% FA; mobile phase B: ACN with 0.1% FA. Data were acquired by a DDA method (data dependent acquisition: 1 full scan plus 12 MS2 scan for the most intense 12 ions). Raw data were submitted to Mascot and searched against UniProt human proteome database. 
